Overview

A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome

Status:
Unknown status

Trial end date:
2020-01-01

Target enrollment:

Participant gender:

Summary

This is a sub-study to ZX008-1503. Subjects will be fitted with an Embrace seizure detection watch and seizures detected by the watch will be compared to those entered into an electronic seizure diary.

Phase:

Phase 3

Details

Lead Sponsor:

Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.

Treatments:

Fenfluramine